Co-injection of CAFs harboring an shRNA-NT construct with HNSCC cells demonstrated enhanced tumor growth, compared to co-injection of CAFs harboring an shRNA-BDNF construct. Here, BDNF is linked to head and neck squamous cell carcinoma.